nach oben

Oral and Maxillofacial Surgery

Erschienen in:

01.09.2010 | Review Article

Management of oral submucous fibrosis: an overview

verfasst von: Punnya V. Angadi, Sanjay Rao

Erschienen in: Oral and Maxillofacial Surgery | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Oral submucous fibrosis is a disease due to a chronic, insidious change in fibroelasticity, characterized by burning sensation in the oral cavity, blanching, and stiffening of the oral mucosa and oro-pharynx leading to trismus and inability to open the mouth. The symptoms and signs depend on the progression of the lesions and number of affected sites. It is predominantly seen in Indians and other Asians. Once, the disease has developed, there is neither regression nor any effective treatment. It is considered as a pre-malignant stage of oral cancer and reported risk of malignant transformation varies from 2.3-7.6%.The common etiological factor considered for this unremitting disease is use of areca nut; however, the precise pathogenesis still remains elusive and controversial. A wide range of treatment consisting of drug management, surgical therapy, and physiotherapy have been attempted till date; with varying degrees of benefit, but none of them have proved to be a cure for this disease. This field remains open for clinical trials and research. This paper aims to provide an overview on various management modalities available for oral submucous fibrosis.

Pindborg JJ, Sirasat SM (1966) Oral submucous fibrosis. Oral surg Oral Med Oral Pathol 22:746–779CrossRef

Canniff JP, Harvey W, Harris M (1986) Oral submucous fibrosis: its pathogenesis and management. Br Dent J 160:429–434PubMedCrossRef

Laskaris G, Bovopoulou O, Nicolis G (1981) Oral submucous fibrosis in a greek female. Br J Oral Surg 19:197–201PubMedCrossRef

Paissat DK (1981) Oral submucous fibrosis. Int J Oral Surg 10:307–312PubMedCrossRef

Sinor PN, Gupta PC, Murti PR (1990) A case control study of oral submucous fibrosis with special reference to the etiologic role of areca nut. J Oral Pathol Med 19:94–98PubMedCrossRef

Joshi SG (1953) Submucous fibrosis of the palate and pillars. Indian J Otolaryngol 4:1–4

Sirasat SM, Pindborg JJ (1967) Subepithelial changes in oral submucous fibrosis. Acta Pathol Microbiol Scand 70:161–173CrossRef

Canniff JP, Harvey W (1981) The aetiology of oral submucous fibrosis: the stimulation of collagen synthesis by extracts of areca nut. Int J Oral Surg 10:163–167PubMed

van Wyk CW, Seedat HA, Phillips VM (1990) Collagen in submucous fibrosis: an electron microscopic study. J Oral Pathol Med 19:182–187PubMedCrossRef

10.

Pindborg JJ, Murti PR, Bhonsle RB, Gupta PC, Daftary DK, Mehta FS (1984) Oral submucous fibrosis as a precancerous condition. Scand J Dent Res 89:270–274

11.

Kwan HW (1976) A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel nut chewing—a preliminary report. J Formos Med assoc 75:497–505

12.

Murti PR, Bhonsle RB, Pindborg JJ, Daftary DK, Gupta PC, Mehta FS (1997) Malignant transformation rate in oral submucous fibrosis over a 17-year period. Community Dent Oral Epidemiol 25:377–383CrossRef

13.

Mani NJ, Singh B (1976) Studies on oral submucous fibrosis-epithelial changes. Oral Surg 41:203–214PubMedCrossRef

14.

Jeng JH, Chang MC, Hahn LJ (2001) Role of areca nut in betel quid associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol 37:477–492PubMedCrossRef

15.

Pindborg JJ, Mehta FS, Gupta PC, Daftary DK (1968) Prevalence of oral submucous fibrosis among 50,915 Indian villagers. Br J Cancer 22:646–654PubMed

16.

Rajalalitha P, Vali S (2005) Molecular pathogenesis of oral submucous fibrosis—a collagen metabolic disorder. J Oral Pathol Med 34:321–328PubMedCrossRef

17.

Cox SC, Walker DM (1996) Oral submucous fibrosis: a review. Aust Dent J 41:294–299PubMedCrossRef

18.

Gupta PC, Sinor PN, Bhonsle RB, Pawar VS, Mehta HC (1998) Oral submucous fibrosis in India: a new epidemic. Natl Med J 11:113–114

19.

Hayes PA (1985) Oral submucous fibrosis in a 4-year-old girl. Oral Surg Oral Med Oral Pathol 59:475–478PubMedCrossRef

20.

Oliver AJ, Radden BG (1992) Oral submucous fibrosis. Case report and review of literature. Aust Dent J 37:31–34PubMedCrossRef

21.

Hamner JE, Looney PD, Chused TM (1974) Submucous fibrosis. Oral Surg 37:412–421PubMedCrossRef

22.

Bhonsle RB, Murti PR, Daftary DK, Gupta PC, Mehta FS, Sinor PN, Irani RR, Pindborg JJ (1987) Regional variations in oral submucous fibrosis in India. Comm Dent Oral Epidemiol 15:225–229CrossRef

23.

Schwartz J (1962) Atrophica idiopathioca (Tropica) Mucosae oris. In: Proceedings of the 11th International Dental Congress, London, 1992 (Cited by Sirasat and Khanolkar. Indian J Med 16:185–197)

24.

Paymaster JC (1956) Cancer of the buccal mucosa: clinical study of 650 cases in Indian patients. Cancer 9:431–435PubMedCrossRef

25.

Hardie J (1987) Oral submucous fibrosis: a review with case reports. J Can Dent Assoc 53:389–393PubMed

26.

Pindborg JJ (1972) Is submucous fibrosis a precancerous condition in the oral cavity? Int Dent 22:474–480

27.

Pindborg JJ, Chawla TN, Srivastara AN, Gupta PD et al (1972) Clinical aspects of oral submucous fibrosis. Acta Odontol Scand 22:679–691CrossRef

28.

Shiau YY, Kwan HW (1979) Submucous fibrosis in Taiwan. Oral Surg 47:454–457CrossRef

29.

Morawetz G, Katsikeris N, Weinberg S, Listorm R (1987) Oral submucous fibrosis. Int J Oral Maxillofac Surg 16:609–714PubMedCrossRef

30.

Pillai R, Balaram P (1992) Pathogenesis of oral submucous fibrosis, relationship to risk factors associated with cancer. Cancer 69:2011–2020PubMedCrossRef

31.

Warnakulasuriya KAAS, Trivedy C, Maher R, Johnson NW (1997) Aetiology of oral submucous fibrosis. Oral Dis 3:286–287

32.

Sinor PN, Gupta PC, Murti PR et al (1990) A case control study of oral submucous fibrosis with special reference to the etiologic role of areca nut. J Oral Pathol Med 19:94–98PubMedCrossRef

33.

Seedat H, Van Wyk CW (1988) Submucous fibrosis in non betel nut chewing subjects. J Biol Buccale 16:3–6PubMed

34.

Seedat HA, Van Wyk CW (1998) Betel nut chewing and submucous fibrosis in Durban. S Afr Med J 74:568–571

35.

Murti PR, Bhonsle RB, Gupta PC, Daftary DK, Pindborg JJ, Mehta FS (1995) Etiology of oral submucous fibrosis with special reference to the role of areca nut chewing. J Oral Pathol Med 24:145–152PubMedCrossRef

36.

Shah N, Sharma PP (1998) Role of chewing and smoking habits in the etiology of oral submucous fibrosis—a case control study. J Oral Pathol Med 27:475–479PubMedCrossRef

37.

Yang YH, Lien YC, Ho PS, Chen CH, Chang JSF, Cheng TC, Shieh TY (2005) The effects of chewing arca/betel quid with and without cigarette smoking on oral submucous fibrosis and oral mucosal lesions. Oral Dis 11:88–94PubMedCrossRef

38.

Yusuf H, Yong SL (2002) Oral submucous fibrosis in a 12-year-old Bangaladeshi boy: a case report and review of literature. Int J Pediatr Dent 12:271–276CrossRef

39.

Ranganathan K, Uma Devi M, Elizabeth J, Kiran Kumar K, Saraswathi TR (2004) Oral submucous fibrosis: a case—control study in Chennai, South India. J Oral Pathol Med 33:274–277PubMedCrossRef

40.

Merchant AT, Haider SM, Fikree FF (1997) Increased severity of oral submucous fibrosis in young Pakistani men. Br J Oral Maxillofac Surg 35:284–287PubMedCrossRef

41.

Tilakaratne WM, Klinikowski MF, Takashi S, Peters TJ, Warnakulasuriya S (2006) Oral submucous fibrosis: review on etiology and pathogenesis. Oral Oncol 42:561–568PubMedCrossRef

42.

Rajendran R (1994) Oral submucous fibrosis:etiology, pathogenesis, and future research. Bull World Health Org 72:985–996PubMed

43.

Murti PR, Gupta PC, Bhonsle RB, Daftary DK, Mehta FS, Pindborg JJ (1990) Effect on the incidence of oral submucous fibrosis of intervention in the areca nut chewing habit. J Oral Pathol Med 19:99–100PubMedCrossRef

44.

Maher R, Lee AJ, Warnakulasuriya KAAS, Lewis JA, Johnson NW (1994) Role of areca nut in the causation of oral submucous fibrosis: a case-control study in Pakistan. J Oral Pathol Med 23:65–69PubMedCrossRef

45.

Reichart PA, Van Wyk CW, Becker J, Schuppan D (1994) Distribution of procollagen typeIII, collagen typeIV and tenascin in oral submucous fibrosis. J Oral Pathol Med 23:394–398PubMedCrossRef

46.

Harvey W, Scutt A, Meghji S, Canniff P (1986) Stimulation of human buccal mucosa fibroblast in vitro by betel nut alkaloids. Arch Oral Biol 31:45–49PubMedCrossRef

47.

Kuo MYP, Chen HM, Hahn LJ, Hsieh CC, Chaian CP (1995) Collagen biosynthesis in human oral submucous fibrosis fibroblast cultures. J Dent Res 74:1783–1788PubMedCrossRef

48.

De Waal J, Olivier A, Van Wyk CW, Maritz JS (1997) The fibroblast population in oral submucous fibrosis. J Oral Pathol Med 26:69–74PubMedCrossRef

49.

Meghji S, Scutt A, Harvey W, Canniff JP (1987) An invitro comparison of human fibroblasts from normal and oral submucous fibrosis tissue. Arch Oral Biol 32:213–215PubMedCrossRef

50.

Haue MF, Meghji S, Khitab U, Harris M (2000) Oral submucous fibrosis patients have altered levels of cytokine production. J Oral Pathol Med 29:123–128CrossRef

51.

Kundendu AB, Radhakrishnan R, Satyamoorthy K (2008) The role of basic fibroblast growth factor in oral submucous fibrosis pathogenesis. J Oral Pathol Med 37:402–411CrossRef

52.

Tsai CH, Yang SF, Chen YJ, Chou MY, Chang YC (2005) Raised keratinocyte growth factor-1 expression in oral submucous in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro. J Oral Pathol Med 34:100–105PubMedCrossRef

53.

Haue MF, Harris M, Meghji S, Spieght PM (1997) An immunohistochemical study of oral submucous fibrosis. J Oral Pathol Med 26:75–82CrossRef

54.

Tsai CH, Yang SF, Chen YJ, My C, Chang YC (2005) The upregulation of insulin-like growth factor-1 in oral submucous fibrosis. Oral Oncol 41:940–946PubMedCrossRef

55.

Haue MF, Harris M, Meghji S, Barret AW (1998) Immunolocalisation of cytokines and growth factors in oral submucous fibrosis. Cytokine 10:713–719CrossRef

56.

Tsai CH, Chou MY, Chang YC (2003) The upregulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral submucous fibrosis. J Oral Pathol Med 32:146–153PubMedCrossRef

57.

Chang YC, Tai KW, Cheng MH, Chou LSS, Chou MY (1998) Cytotoxic and nongenotoxic effects of arecoline on human buccal mucosal fibroblasts in vitro. J Oral Pathol Med 27:68–71PubMedCrossRef

58.

Chui CJ, Chang ML, Chaing CP, Hahn LJ, Hsieh LL, Chaen CJ (2002) Interaction of collagen-related genes and susceptibility to betel quid induced oral submucous fibrosis. Cancer Epidemiol Biomark Prev 11:646–653

59.

Chiu CJ, Cp C, Chang ML (2001) Association between genetic polymorphism of tumor necrosis factor alpha and risk of oral submucous fibrosis, a precancerous condition of oral cancer. J Dent Res 80:2055–2059PubMedCrossRef

60.

Lui CJ, Lee YJ, Chang KW, Sinh YN, Liu HF, Dang CW (2004) Polymorphism of the MICA gene and risk for oral submucous fibrosis. J Oral Pathol Med 33:1–6CrossRef

61.

Shin YN, Lui CJ, Chang KW, Lee YY, Lui HF (2004) Association of CTLA-4 gene polymorphism with oral submucous fibrosis in Taiwan. J Oral Pathol Med 33:1–6CrossRef

62.

Tu HF, Liu CJ, Chang CS, Lui MT, Kao SY, Chang CP, Liu TY (2006) The functional (−1171 5A → 6A) polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral submucous fibrosis among male areca users. J Oral Pathol Med 35:99–103PubMedCrossRef

63.

Utsunomiya H, Tilakaratne WM, OshiroK MS, Suzuki M, Ida-Yonemochi H, Cheng J, Saku T (2005) Extracellular matrix remodeling in oral submucous fibrosis: its stage-specific modes revealed by immunohistochemistry and in situ hybridization. J Oral Pathol Med 34:498–507PubMedCrossRef

64.

Scutt A, Meghji S, Canniff JP, Harvey W (1987) Stabilisation of collagen by betel nut polyphenols as a mechanism in oral submucous fibrosis. Experimentia 43:391–393CrossRef

65.

Meghji S, Scutt A, Canniff JP, Harvey W, Phillipson JD (1982) Inhibition of collagenase activity by areca nut tannins: a mechanism of collagen accumulation in oral submucous fibrosis. J Dent Res 61:545

66.

Shieh TY, Yang JF (1992) Collagenase activity in oral submucous fibrosis. Pro Natl Sci Counc China B 16:106–110

67.

Shieh DH, Chiang LC, Shieh TY (2003) Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and saffrole as a possible pathogenesis for oral submucous fibrosis. Oral Oncol 39:728–735PubMedCrossRef

68.

Chang YC, Yang SF, Tai KW, Chou MY, Hsieh YS (2002) Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis. Oral Oncol 38:195–200PubMedCrossRef

69.

Yang SF, Hsieh YS, Tsai CH, Chou MY, Chang YC (2003) The upregulation of typeI plaminogen activator inhibitor in oral submucous fibrosis. Oral Oncol 39:367–372PubMedCrossRef

70.

Rajendran R, Vijaykumar T, Vasudevan DM (1989) An alternative pathogenic pathway for oral submucous fibrosis. Med Hypotheses 30:231–239CrossRef

71.

Tsai CC, Ma RH, Shieh TY (1999) Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis. J Oral Pathol Med 28:59–63PubMedCrossRef

72.

Shieh DH, Chiang LC, Lee CH, Yang YH, Shieh TY (2004) Effects of arecoline, saffrole and nicotine on collagen phagocytosis by human buccal mucosal fibroblasts as a possible mechanism for oral submucous fibrosis. J Oral pathol Med 33:581–587PubMedCrossRef

73.

Tsai Ch, Yang SF, Chang YC (2007) The upregulation of cystatin C in oral submucous fibrosis. Oral Oncol 43:680–685CrossRef

74.

Trivedy C, Warnakulasuriya KAAS, Hazarey VK, Tavassoli M, Sommer P, Johnson NW (1999) The upregulation of lysyl oxidase in oral submucous fibrosis and squamous cell carcinoma. J Oral Pathol Med 28:246–251PubMedCrossRef

75.

Trivedy CR, Warnakulasuriya KAAS, Peter TJ, Senkus R, Hazarey VK, Johnson NW (2000) Raised tissue copper levels in oral submucous fibrosis. J Oral Pathol Med 29:241–248PubMedCrossRef

76.

Trivedy CR, Meghji S, Warnakulasuriya KAAS, Johnson NW, Harris M (2001) Copper stimulates human oral fibroblasts in vitro: a role in the pathogenesis of oral submucous fibrosis. J Oral Pathol Med 30:465–470PubMedCrossRef

77.

Trivedy CR, Warnakulasuriya KA, Peters TJ, Senkus R, Hazarey VK, Johnson NW (2000) Raised tissue copper levels in oral submucous fibrosis. J Oral Pathol Med 29:241–248PubMedCrossRef

78.

Trivedy C, Baldwin D, Warnakulasuriya S, Johnson NW, Peters T (1997) Copper content in Areca catechu (betel nut) products and oral submucous fibrosis. Lancet 349:1447PubMedCrossRef

79.

Ma RH, Tsai CC, Shieh TY (1995) Increased lysyl oxidase activity in fibroblasts cultured from oral submucous fibrosis associated with betel nut chewing in Taiwan. J Oral Pathol Med 24:407–412PubMedCrossRef

80.

Haue MF, Meghji S, Nazir R, Harris M (2001) Interferon gamma may reverse oral submucous fibrosis. J Oral Pathol Med 30:12–21CrossRef

81.

Chiang CP, Hsieh RP, Chen TH (2002) High incidence of autoantibodies in Taiwanese patients with oral submucous fibrosis. J Oral Pathol Med 31:402–409PubMedCrossRef

82.

Khanna SS, Karjodkar FR (2006) Circulating immune complexes and trace elements (copper, iron and selenium) as markers in oral precancer and cancer: a randomised, controlled clinical. Head Face Med 2:33PubMedCrossRef

83.

Ghosh PK, Madhavi R, Guntur M, Ghosh R (1990) Sister chromatid exchanges in patients with oral submucous fibrosis. Cancer Genet Cytogenet 44:197–201PubMedCrossRef

84.

Chiang CP, Wu HY, Lui BY, Wang JT, Kuo MYP (2002) Quantitative analysis of immunocompetent cells in oral submucous fibrosis in Taiwan. Oral Oncol 38:56–63PubMedCrossRef

85.

Gupta DS, Gupta MK, Oswal RH (1985) Estimation of major immunoglobulin profile in oral submucous fibrosis by radial immunodiffusion. Int J Oral Surg 14:533–537PubMedCrossRef

86.

Shah N, Kumar R, Shah MK (1994) Immunological studies in oral submucous fibrosis. Indian J Dent Res 5:81–87PubMed

87.

Canniff JP, Batchelor JR, Dodi IA, Harvey W (1982) HLA typing in oral submucous fibrosis. Tissue Antigens 26:138–142CrossRef

88.

Saeed B, Haue MF, Meghji S, Harris M (1997) HLA typing in oral submucous fibrosis. J Dent Res 76:1024

89.

Chen HM, Hsieh RP, Yang H, Kuo YS, Kuao MYP, Chaing CP (2004) HLA antigens in oral submucous fibrosis. J Oral Pathol Med 33:191–199PubMedCrossRef

90.

Van Wyk CW, Grobler Rabie AF, Martel RW, Hammond MG (1994) HLA antigens in oral submucous fibrosis. J Oral Pathol Med 23:23–27PubMedCrossRef

91.

Khanna JN, Andrade NN (1995) Oral submucous fibrosis: a new concept in surgical management. Report of 100 cases. Int J Oral Maxillofac Surg 24:433–449PubMedCrossRef

92.

Katharia SK, Singh SP, Kulshrestha VK (1992) The effects of placental extract in management of oral submucous fibrosis. Ind J Pharmacology 24:181–183

93.

Jiang X, Jing Hu (2009) Drug treatment of oral submucous fibrosis: a review of the literature. J Oral Maxillofac Surg 67:1510–1515PubMedCrossRef

94.

Aziz RS (2008) Oral submucous fibrosis: case report and review of diagnosis and treatment. J Oral Maxillofac Surg 66:2386–2389PubMedCrossRef

95.

Fedorowicz Z, Chan Shih YE, Naseer M, Newton T, Shi L (2009) Interventions for the management of oral submucous fibrosis: a review. Cochrane collaboration 2009

96.

Tai YS, Liu BY, Wang JT, Sun A, Kwan HW, Chaing CP (2001) Oral administration of milk from cows immunized with human intestinal bacteria leads to significant improvements of symptoms and signs in patients with oral submucous fibrosis. J Oral Pathol Med 30:618–625PubMedCrossRef

97.

Jirge V, Ali SM, Anshumalee N (2009) Levamisole and antioxidants in management of oral submucous fibrosis: a comparative study. J Ind Acad Oral Med Radiol 20:135–139CrossRef

98.

Rajendran R, Rani V, Shaikh S (2006) Pentoxyfylline therapy: a new adjunct in treatment of oral submucoau fibrosis. Indian J Dent Res 17:190–198PubMedCrossRef

99.

Lai DR, Chen HR, Lin LM (1995) Clinical evaluation of different treatament methods for oral submucous fibrosis: a 10-year experience with 150 cases. J Oral Pathol Med 24:402–407PubMedCrossRef

100.

Sharma JK, Gupta AK, Mukhija RD (1987) Clinical experience with use of peripheral vasodilator in oral disorders. Int J Oral Maxillofac Surg 16:695PubMedCrossRef

101.

Li XM, Tang J (1998) Clinical treatment obserevation of tea pigment for oral submucous fibrosis. Hua Xi Kou iang YI Xue Za Zhi 16:50–55

102.

Gupta S, Reddy MVR, Harinath BC (2004) Role of oxidative stress and antioxidants in aetiopathogeneisi and management of oral submucous fibrosis. Indian J Clin Biochem 19:138–139CrossRef

103.

Singh M, Krishnappa R, Bagewadi A (2004) efficacy of oral lycopene in the treatment of oral submucous fibrosis. Oral Oncol 40:591PubMedCrossRef

104.

Kumar A, Bagewadi A, Keluskar V, Singh M (2007) Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103:207–213PubMedCrossRef

105.

Lin HJ, Lin JC (2007) Treatment of oral submucous fibrous by collagenases: effects on oral opening and eating functions. Oral Dis 13:407–413PubMedCrossRef

106.

Dai JP, Chen J, Bei YF, Han BX, Wang S (2009) Influence of borneol on primary mice oral fibroblasts: a penetration-enhancer may be used in oral submucous fibrosis. J Oral Pathol Med 38:276–281PubMedCrossRef

107.

Yen DJC (1982) Surgical treatment of submucous fibrosis. Oral Surg 54:269–272PubMedCrossRef

108.

Haung IY, Wu C, Shen Y, Yang C, Shieh T, Hsu H (2008) Importance of patient’s cooperation in surgical treatment for oral submucous fibrosis. J Oral Maxillofac Surg 66:699–703CrossRef

109.

Kavarana NM, Bhatena H (1987) Surgery for severe trismus in submucous fibrosis. Br J Plast Surg 40:407–409PubMedCrossRef

110.

Mehrotra D, Pradhan R, Gupta S (2009) Retrospective comparison of surgical treatment modalities in 100 patients with oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107:e1–e10PubMedCrossRef

111.

Chen CM, Yang CF, Shen YS, Huang IY, Wu CF (2008) The use of artificial dermis for surgical defects in the treatment of oral premalignant lesions. J Surg Oncol 97:291–293PubMedCrossRef

112.

Chao CK, Chang LC, Liu SY, Wang JJ (2002) Histologic examination of pedicled buccal fat pad graft in oral submucous fibrosis. J Oral Maxillofac Surg 60:1131–1134PubMedCrossRef

113.

Lai DR, Chen HR, Huang YL, Tsai CC (1995) Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases. J Oral Pathol Med 24:402–406PubMedCrossRef

114.

Mokal NJ, Raje RS, Ranade SV, Rajendra Prasad JS, Thatte RL (2005) Release of oral submucous fibrosis and reconstruction using superficial temporal fascia flap and split skin graft—a new technique. Br J Plast Surg 58:1055–1060PubMedCrossRef

115.

Borle RM, Nimonkar PV, Rajan R (2009) Extended nasolabial flaps in the management of oral submucous fibrosis. Br J Oral Maxillofac Surg 47:382–385PubMedCrossRef

116.

Tsao CK, Wei FC, Chang YM, Cheng MH, Chaug DC, Kao HK (2009) Reconstruction of the buccal mucosa following release for submucous fibrosis using two radial forearm flaps from asingle donor site. J Plast Recon Aesth Surg (in press)

117.

Omura S, Mizuki N, Horimoto R, Kawabe R, Fujita K (1997) A newly developed collage/silicone bilayer membrane as a mucosal substitute: a preliminary report. Br J Oral Maxillofac Surg 35:85–91PubMedCrossRef

118.

Huang JJ, Wallace C, Lin JY, Tsao CK, Kao HK, Huang WC (2009) Two small flaps from one anterolateral thigh donor site for bilateral buccal mucosa reconstruction after release of submucous fibrosis and/or contracture. J Plast Recon Aesth Surg. (in press)

119.

Le PV, Gornitsky M (1996) Oral stent as treatment adjunct for oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81:148–150PubMedCrossRef

120.

Cox S, Zoellner H (2009) Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. J Oral Pathol Med 38:220–226PubMedCrossRef

121.

Patil PG, Parkhedkar RD (2009) New graft stabilizing clip as a treatment adjunct for oral submucous fibrosis. J Prosth Dent 102:191–192CrossRef

122.

Huang IY, Wu CF, Shen YS, Yang CF, Shieh TY, Hsu HJ et al (2008) Importance of patient’s cooperation in surgical treatment of oral submucous fibrosis. J Oral Maxillofac Surg 66:699–703PubMedCrossRef

Titel: Management of oral submucous fibrosis: an overview
verfasst von: Punnya V. Angadi
Sanjay Rao
Publikationsdatum: 01.09.2010
Verlag: Springer-Verlag
Erschienen in: Oral and Maxillofacial Surgery / Ausgabe 3/2010
Print ISSN: 1865-1550
Elektronische ISSN: 1865-1569
DOI: https://doi.org/10.1007/s10006-010-0209-x

Neu im Fachgebiet Chirurgie

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Management of oral submucous fibrosis: an overview

Abstract

Neu im Fachgebiet Chirurgie

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Darf man die Behandlung eines Neonazis ablehnen?

Deutlich weniger Infektionen: Wundprotektoren schützen!

Chirurginnen und Chirurgen sind stark suizidgefährdet

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2010

Clinical evaluation of the alar base width of patients submitted to surgically assisted maxillary expansion

Mucosal malignant melanomas in head and neck surgery: a retrospective study of six patients and review of the literature

Limited mouth opening after primary therapy of head and neck cancer

Traumatic displacement of maxillary permanent incisor into the nasal cavity

Maxillary sinus aplasia

Endotracheal tube tailored as surgical stent—technical note

Update Chirurgie